Researchers studied the effectiveness of antiseizure medications (ASMs) for treating epilepsy in children with Cyclin-dependent kinase-like 5 deficiency disorder (CDD), a serious condition that often leads to drug-resistant seizures.
Researchers studied a young patient with epilepsy who was being treated with a medication called valproate.
This study focused on children with tuberous sclerosis complex (TSC) who experience epilepsy.
This study looked at how to best treat brain cavernomas, which are abnormal blood vessel clusters in the brain that can cause symptoms like seizures or bleeding.
Researchers studied the effects of a type of diabetes medication called glucagon-like peptide-1 receptor agonists (GLP-1RAs) in adults with type 2 diabetes (T2D).
This study looked at how genetic testing is used to diagnose neurodevelopmental disorders (NDDs) in Israel, focusing on children born between 2000 and 2020.
This study looked at people with drug-resistant focal epilepsy who had negative MRI results, meaning no visible lesions were found on their scans.
Researchers studied the safety and effectiveness of quickly giving antiseizure medications (ASMs) to patients, focusing on three specific drugs: lacosamide, levetiracetam, and valproate.
This study looked at how medical cannabis is regulated in the United States, the European Union, and the United Kingdom.